(MedPage Today) — CHICAGO — Champions of tricuspid transcatheter edge-to-edge repair (TEER) were buoyed by 2-year results of the TRILUMINATE trial marking the first report of reduced heart failure (HF) hospitalization for this technology….
Source link : https://www.medpagetoday.com/meetingcoverage/acc/114921
Author :
Publish date : 2025-04-01 19:44:00
Copyright for syndicated content belongs to the linked Source.
